MAPS

TDR’s Top 5 Psychedelic Developments For The Week Of July 12

Jul 17, 2021

MDMA For PTSD: Health Canada Approves Numinus’ MAPS-Sponsored Study

Jul 16, 2021

Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

Jul 12, 2021

What Is A Compassionate Access Trial? Numinus CSO & Co-Founder Stacey Wallin Has The Details

Jun 7, 2021

What The Results Of The Latest MAPS MDMA Trial For PTSD Mean For Numinus

May 31, 2021

TDR’s Top 5 Psychedelic Developments For the Week of February 15

Feb 20, 2021

Numinus Wellness: Building A Comprehensive Psychedelic-Assisted Therapy Ecosystem

Feb 1, 2021

Research Continues on MDMA-Assisted Therapy to Help PTSD Patients and War Veterans

Oct 7, 2020

Numinus Wellness Inc. Begins Cultivating Mushrooms At Health Canada Lab

Oct 1, 2020